Oncolytics Biotech (ONCY) Non-cash Items (2009 - 2020)

Oncolytics Biotech's (ONCY) quarterly Non-cash Items came in at -$68789.0 in Q3 2020, down 100.43% on a QoQ basis from $16.1 million in Q4 2010.

Oncolytics Biotech (ONCY) Non-cash Items (2009 - 2020) Analysis & Trends

Oncolytics Biotech (ONCY) has 3 years of Non-cash Items data on file, last reported at -$68789.0 in Q3 2020.

On a quarterly basis, Non-cash Items changed N/A year-over-year to -$68789.0 in Q3 2020; TTM through Sep 2020 was $6.7 million, a N/A change from a year earlier, with the FY2010 full-year figure at $1.8 million, up 1558.99% from the prior year.
Non-cash Items for Q3 2020 stood at -$68789.0, down from $16.1 million in the prior quarter.
Over the last five years, Non-cash Items for ONCY reached as high as -$68789.0 in Q3 2020 and fell as low as -$68789.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn
4	NuCana	279.75 Bn	279.75 Bn	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn
7	Belite Bio	62.51 Bn	62.51 Bn	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-
10	Oncolytics Biotech	372.40 Mn	372.40 Mn	-

Download Data